1. Gupta, Abha R, Pirruccello, Michelle, Cheng, Feng, Sestan, Nenad, State, Matthew W. 2014. Rare deleterious mutations of the gene EFR3A in autism spectrum disorders. In Molecular autism, 5, 31. doi:10.1186/2040-2392-5-31. https://pubmed.ncbi.nlm.nih.gov/24860643/
2. Trybus, Magdalena, Hryniewicz-Jankowska, Anita, Wójtowicz, Karolina, Czogalla, Aleksander, Sikorski, Aleksander F. 2023. EFR3A: a new raft domain organizing protein? In Cellular & molecular biology letters, 28, 86. doi:10.1186/s11658-023-00497-y. https://pubmed.ncbi.nlm.nih.gov/37880612/
3. Adhikari, Hema, Kattan, Walaa E, Kumar, Shivesh, Hancock, John F, Counter, Christopher M. 2021. Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity. In Nature communications, 12, 5248. doi:10.1038/s41467-021-25523-5. https://pubmed.ncbi.nlm.nih.gov/34504076/
4. Zhao, Kai, Bai, Xuexue, Wang, Xiao, Li, Wei, Wang, Shiyong. 2023. Insight on the hub gene associated signatures and potential therapeutic agents in epilepsy and glioma. In Brain research bulletin, 199, 110666. doi:10.1016/j.brainresbull.2023.110666. https://pubmed.ncbi.nlm.nih.gov/37192718/
5. Nie, Chen, Hu, Haixia, Shen, Chenling, Wu, Hao, Xiang, Mingliang. 2015. Expression of EFR3A in the mouse cochlea during degeneration of spiral ganglion following hair cell loss. In PloS one, 10, e0117345. doi:10.1371/journal.pone.0117345. https://pubmed.ncbi.nlm.nih.gov/25622037/
6. Jiang, Pan, Xia, Binghua. 2023. Circular RNA EFR3A promotes nasopharyngeal carcinoma progression through modulating the miR-654-3p/EFR3A axis. In Cellular and molecular biology (Noisy-le-Grand, France), 69, 111-117. doi:10.14715/cmb/2023.69.12.18. https://pubmed.ncbi.nlm.nih.gov/38063110/
7. Hoellerbauer, Pia, Biery, Matt C, Arora, Sonali, Pritchard, Justin R, Paddison, Patrick J. 2023. Functional genomic analysis of adult and pediatric brain tumor isolates. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.01.05.522885. https://pubmed.ncbi.nlm.nih.gov/36711964/
8. Liu, Xiaomin, Xu, Hanshi, Xu, Huaiqian, Liu, Xiao, Zhong, Shilong. 2021. New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin. In The pharmacogenomics journal, 21, 664-672. doi:10.1038/s41397-021-00245-5. https://pubmed.ncbi.nlm.nih.gov/34158603/